Parallel Health

Parallel Health

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.parallelhealth.io

Last Round

Pre Seed

Sep 21, 2023

Total Funding Raised

$2.3M

Company Overview

Parallel Health is a precision skin health company that provides personalized skincare solutions by leveraging microbial genomics, AI-enabled phage therapy, and big data analysis. The company offers an at-home Skin Discovery Test that uses whole-genome sequencing to analyze a user's skin microbiome. Based on the results, Parallel Health provides personalized phage-based products, custom prescriptions, and one-on-one clinical support to address various skin conditions such as acne, eczema, rosacea, and signs of aging. Their approach, termed Microbiome Dermatology™, aims to selectively target and eliminate pathogenic bacteria while preserving beneficial microbes.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Telemedicine, D2C Brands, Subscription Commerce

Business Model

B2C

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

phage therapypersonalized skincareskin microbiometeledermatologymicrobiome skincarephage serumD2C skincarewhole genome sequencingat-home skin testsubscription skincarecustom skincareonline dermatologistacne treatmentbiotech skincarecustom prescriptionHSA/FSA eligibleB2B health analytics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Parallel Health Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Parallel Health Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Pre SeedSep 21, 2023
GrantSep 20, 2022
AcceleratorFeb 8, 2021

Key People

Founding team and executive leadership

Nathan Brown

Co-founder And Chief Science Officer

Founding Team

Đinh Minh Hoàng

Founder CEO

Founding Team

Natalise Kalea Robinson

Co-Founder CEO

Founding Team

Parallel Health Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 17, 2026

    CEO named to Inc.'s 2026 Female Founders 500 list.

  • Feb 8, 2021

    Completed an Accelerator round of funding.

Parallel Health Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Parallel Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Parallel Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range11
Year Founded2020
Last FundingSep 21, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.